How Big Is the Infectious Disease Drug Market | Growth Analysis 2032

Q: What will the infectious disease drug market be worth?

The infectious disease drug market is forecast to exceed USD 112.2 billion by 2031, supported by rising demand for effective treatments and vaccines.

Q: Who are the major players in the infectious disease drug market?

Major players include Pfizer, GSK, Merck & Co., Johnson & Johnson, Roche, and Gilead Sciences, known for their strong portfolios in antivirals, antibiotics, and vaccines.

Q: How is innovation shaping the infectious disease drug market?

The infectious disease drug market is being transformed through RNA therapeutics, global funding programs, and fast-tracked regulatory pathways.

Q: What challenges are influencing the infectious disease drug market?

Challenges such as antimicrobial resistance and supply chain access are key factors influencing strategies in the infectious disease drug market.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA6668

Publication Date: Jul 2025

How Big Is the Infectious Disease Drug Market?

According to 6Wresearch internal database and industry insights, the Global Infectious Disease Drug Market was valued at USD 68.3 billion in 2026 and is projected to surpass USD 112.2 billion by 2032, expanding at a CAGR of 8.00%.

For detailed forecasts, data tables, and competitive benchmarking,
Explore the full Global Infectious Disease Drug Market.

View Main Report Schedule Analyst Call

This growth is fuelled by the increasing prevalence of viral and bacterial infections, growing resistance to existing antibiotics, and the demand for rapid treatment solutions. The rise of zoonotic diseases, urban overcrowding, and global health preparedness initiatives are further supporting market expansion. Biotech innovations and collaborations between pharmaceutical firms and health organizations are also boosting development pipelines.

Growth Factors of the Infectious Disease Drug Market

Increasing incidence of drug-resistant bacterial and viral infections
Increasing funding for epidemic readiness and control
Increasing pipelines of antivirals, antibiotics, and vaccines
Increasing demand for accessible and rapid treatments
Growing public and private partnerships focused on innovation and development and research

Infectious Disease Drug Market Trends

The infectious disease drug market is shifting to include novel antimicrobial agents, combination therapies and personalized medicine. There is strong demand for oral antivirals for diseases such as influenza and COVID-19. The emphasis on global equitable access to treatment influences development, manufacturing, and distribution.

Emerging Developments in the Infectious Disease Drug Market

The developments in the Infectious Disease Drug Market include new forms of RNA-based therapies, new reformulations for paediatric populations, new types of vaccines administered in innovative ways, and new global collaborations for addressing antimicrobial resistance that is driving investment in new antibiotics. The fast-track designation of regulatory procedures to help prioritize high-impact infections is becoming a common trend, too.